WallStreetZenWallStreetZen

NASDAQ: CDT
Conduit Pharmaceuticals Revenue

OverviewEarningsRevenue
DividendOwnership
Conduit Pharmaceuticals revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CDT annual revenue was $0.0, with N/A growth year-over-year.

CDT revenue history

Current Revenue
$0.0
Current Earnings
-$17.8M
Current Profit Margin
0%

Be the first to know when CDT announces revenue.

CDT Revenue History By Year

CDT Yearly RevenueCDT RevenueCDT ChangeCDT Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A

1 of 1

Conduit Pharmaceuticals Revenue FAQ

What was CDT's revenue last quarter?

Conduit Pharmaceuticals (NASDAQ: CDT) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Conduit Pharmaceuticals's revenue was $0.00.

What was Conduit Pharmaceuticals's revenue in 2024?

Conduit Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Conduit Pharmaceuticals make in a day?

Based on Conduit Pharmaceuticals annual revenue for the past three years, CDT makes an average of $0.00 per day.

What was Conduit Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Conduit Pharmaceuticals's revenue has grown null year over year. Conduit Pharmaceuticals's revenue in the past year totaled $0.00.

How much does Conduit Pharmaceuticals make in a year?

Conduit Pharmaceuticals's revenue by year for the past three years is:
  • Conduit Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Conduit Pharmaceuticals's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Conduit Pharmaceuticals's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.